LTBP2 and pulmonary arterial hypertension: They identified a panel of proteins upregulated in both RV and plasma of patients with PAH with decompensated RVs and further identified latent transforming growth factor beta binding protein 2 (LTBP-2) as a novel plasma biomarker in PAH that correlates with RV function and predicts long-term survival.